Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Harvard Business School
Mallinckrodt
McKesson
Medtronic

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Claims for Patent: 6,280,993

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,280,993
Title: Gene encoding class I collagenase
Abstract:An isolated DNA encoding a class I collagenase, particularly, the isolated DNA encoding the class I collagenase from Clostridium histolyticum, a vector containing the gene, a transformant containing the vector, a class I collagenase, and a method of preparing the class I collagenase are disclosed.
Inventor(s): Yamato; Ichiro (Tokyo 158-0097, JP), Hosaka; Toshiaki (Chiba, JP)
Assignee: Yamato; Ichiro (Tokyo, JP)
Application Number:09/379,523
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,280,993
Patent Claims:1. A class I collagenase of SEQ ID NO: 3.

2. A protein consisting of amino acids 110 to 1118 of SEQ ID NO: 3.

3. A fusion protein of a protein consisting of amino acids 110 to 1118 of SEQ ID NO: 3 and a fusion partner.

4. An isolated DNA encoding a class I collagenase of SEQ ID NO: 3.

5. An isolated DNA consisting of the DNA sequence of SEQ ID NO: 4.

6. An isolated DNA encoding a protein consisting of amino acids 110 to 1118 of SEQ ID NO: 3.

7. An isolated DNA encoding a fusion protein of a protein consisting of amino acids 110 to 1118 of SEQ ID NO: 3 and a fusion partner.

8. A vector comprising the isolated DNA according to claim 4.

9. A vector comprising the isolated DNA according to claim 5.

10. A vector comprising the isolated DNA according to claim 6.

11. A vector comprising the isolated DNA according to claim 7.

12. A transformant comprising the vector according to claim 8.

13. A transformant comprising the vector according to claim 9.

14. A transformant comprising the vector according to claim 10.

15. A transformant comprising the vector according to claim 11.

Details for Patent 6,280,993

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Start Trial Yamato; Ichiro (Tokyo, JP) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
AstraZeneca
Medtronic
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.